Your browser version may not work well with NCBI's Web applications. More information here...
1: Biochemistry. 2002 Oct 8;41(40):12244-52.
Related Articles, Links
Click here to read
Structural and biochemical characterization of a fluorogenic rhodamine-labeled malarial protease substrate.

Blackman MJ, Corrie JE, Croney JC, Kelly G, Eccleston JF, Jameson DM.

National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, U.K. mblackm@nimr.mrc.ac.uk

Activation of the proenzyme form of the malarial protease PfSUB-1 involves the autocatalytic cleavage of an Asp-Asn bond within the internal sequence motif (215)LVSADNIDIS(224). A synthetic decapeptide based on this sequence but with the N- and C-terminal residues replaced by cysteines (Ac-CVSADNIDIC-OH) was labeled with 5- or 6-isomers of iodoacetamidotetramethylrhodamine (IATR). The doubly labeled peptides have low fluorescence because of ground-state, noncovalent dimerization of the rhodamines. Cleavage of either peptide by recombinant PfSUB-1 results in dissociation of the rhodamine dimers, which abolishes the self-quenching and consequently leads to an approximately 30-fold increase in the fluorescence. This spectroscopic signal provides a continuous assay of proteolysis, enabling quantitative kinetic measurements to be made, and has also enabled the development of a fluorescence-based assay suitable for use in high-throughput screens for inhibitors of PfSUB-1. The structure of the rhodamine dimer in the 6-IATR-labeled peptide was shown by NMR to be a face-to-face stacking of the xanthene rings. Time-resolved fluorescence measurements suggest that the doubly labeled peptides exist in an equilibrium consisting of rhodamines involved in dimers (closed forms) and rhodamines not involved in dimers (open forms). These data also indicate that the rhodamine dimers fluoresce and that the associated lifetimes are subnanosecond.

Publication Types:
PMID: 12356327 [PubMed - indexed for MEDLINE]